Chosa Oncology AB
Research Chosa Oncology AB (W5L) on Bullrun: market cap EUR 7.07M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerW5L
- ExchangeF
- CountrySweden
- SectorHealthcare
- IndustryBiotechnology
- CurrencyEUR
- Market capEUR 7.07M
- Financial periodQ4 2025
- Net incomeEUR 699.00K
- Free cash flow-EUR 819.00K
Valuation Snapshot
latest market cap is EUR 7.07M.
About Chosa Oncology AB
Chosa Oncology AB, together with its subsidiaries, engages in developing and commercializing medicines for the treatment of cancer in Sweden. It provides Platin-DRP, a multigene mRNA-based algorithm that predicts a patient's response to platinum-based chemotherapy; and LiPlaCis, a liposomal formulation of cisplatin, enabling delivery of chemotherapy agent directly to tumor sites. The company was formerly known as Chosa ApS. Chosa Oncology AB was incorporated in 2015 and is based in Malmö, Sweden.
Frequently asked questions
What is Chosa Oncology AB's market cap?
Chosa Oncology AB's market capitalization is EUR 7.07M.
What does Chosa Oncology AB do?
Chosa Oncology AB, together with its subsidiaries, engages in developing and commercializing medicines for the treatment of cancer in Sweden. It provides Platin-DRP, a multigene mRNA-based algorithm that predicts a patient's response to platinum-based chemotherapy;